Matches in SemOpenAlex for { <https://semopenalex.org/work/W287470912> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W287470912 abstract "Binding studies were carried out in human fat cell membranes with two alpha 2-adrenergic antagonists, (3H)idazoxan and its methoxy derivative (3H)RX821002. Inhibition studies with epinephrine enantiomers indicate that (3H)RX821002 only binds to alpha 2-adrenoceptors, whereas (3H)idazoxan labels alpha 2-adrenoceptors and additional nonadrenergic sites (NAIBS). NAIBS and alpha 2-adrenoceptors display different affinities towards drugs from various chemical families. Imidazoline and some guanidine derivatives exhibit a high affinity for NAIBS. Pharmacological studies of human NAIBS indicate that they are slightly different from those previously reported in the rabbit, suggesting the existence of several subtypes of NAIBS. Furthermore, NAIBS are different from the previously described imidazoline-preferring sites. (3H)idazoxan and (3H)RX821002 saturation analyses were performed in human adipocytes from different anatomical locations, in order to compare the number of NAIBS and alpha 2-adrenoceptors. Although there was an important variation in NAIBS and alpha 2-adrenoceptor numbers in the studied samples, a very poor correlation was obtained between the Bmax values of the two sites. Moreover, alkylation of alpha 2-adrenoceptors by phenoxybenzamine produces a 90% reduction in accessible (3H)RX821002 binding sites, without modification of (3H)idazoxan binding. These data show that NAIBS are not closely related to the alpha 2-adrenergic molecule. In addition, benextramine appears to bemore » a reversible competitor at NAIBS. (3H)idazoxan binding, but not (3H)RX821002 binding, is sensitive to K+, suggesting that the domains involved in the ligand-NAIBS interaction are different from those involved in the ligand-alpha 2-adrenoceptor interaction.« less" @default.
- W287470912 created "2016-06-24" @default.
- W287470912 creator A5011234349 @default.
- W287470912 creator A5035925658 @default.
- W287470912 creator A5045447026 @default.
- W287470912 date "1990-06-01" @default.
- W287470912 modified "2023-09-24" @default.
- W287470912 title "Binding of ( sup 3 H)idazoxan and of its methoxy derivative ( sup 3 H) RX821002 in human fat cells: ( sup 3 H)idazoxan but not ( sup 3 H) RX821002 labels additional non-alpha 2-adrenergic binding sites" @default.
- W287470912 hasPublicationYear "1990" @default.
- W287470912 type Work @default.
- W287470912 sameAs 287470912 @default.
- W287470912 citedByCount "0" @default.
- W287470912 crossrefType "journal-article" @default.
- W287470912 hasAuthorship W287470912A5011234349 @default.
- W287470912 hasAuthorship W287470912A5035925658 @default.
- W287470912 hasAuthorship W287470912A5045447026 @default.
- W287470912 hasConcept C116569031 @default.
- W287470912 hasConcept C123605464 @default.
- W287470912 hasConcept C134018914 @default.
- W287470912 hasConcept C170493617 @default.
- W287470912 hasConcept C185592680 @default.
- W287470912 hasConcept C2776885963 @default.
- W287470912 hasConcept C2778680573 @default.
- W287470912 hasConcept C2778938600 @default.
- W287470912 hasConcept C2780307058 @default.
- W287470912 hasConcept C2780648677 @default.
- W287470912 hasConcept C2780939551 @default.
- W287470912 hasConcept C40465926 @default.
- W287470912 hasConcept C55493867 @default.
- W287470912 hasConcept C71240020 @default.
- W287470912 hasConcept C86803240 @default.
- W287470912 hasConceptScore W287470912C116569031 @default.
- W287470912 hasConceptScore W287470912C123605464 @default.
- W287470912 hasConceptScore W287470912C134018914 @default.
- W287470912 hasConceptScore W287470912C170493617 @default.
- W287470912 hasConceptScore W287470912C185592680 @default.
- W287470912 hasConceptScore W287470912C2776885963 @default.
- W287470912 hasConceptScore W287470912C2778680573 @default.
- W287470912 hasConceptScore W287470912C2778938600 @default.
- W287470912 hasConceptScore W287470912C2780307058 @default.
- W287470912 hasConceptScore W287470912C2780648677 @default.
- W287470912 hasConceptScore W287470912C2780939551 @default.
- W287470912 hasConceptScore W287470912C40465926 @default.
- W287470912 hasConceptScore W287470912C55493867 @default.
- W287470912 hasConceptScore W287470912C71240020 @default.
- W287470912 hasConceptScore W287470912C86803240 @default.
- W287470912 hasLocation W2874709121 @default.
- W287470912 hasOpenAccess W287470912 @default.
- W287470912 hasPrimaryLocation W2874709121 @default.
- W287470912 hasRelatedWork W1519748854 @default.
- W287470912 hasRelatedWork W1849954389 @default.
- W287470912 hasRelatedWork W1865252654 @default.
- W287470912 hasRelatedWork W1935384768 @default.
- W287470912 hasRelatedWork W1944422455 @default.
- W287470912 hasRelatedWork W1999691892 @default.
- W287470912 hasRelatedWork W2014054280 @default.
- W287470912 hasRelatedWork W2025339335 @default.
- W287470912 hasRelatedWork W2034959593 @default.
- W287470912 hasRelatedWork W2037584093 @default.
- W287470912 hasRelatedWork W2043192122 @default.
- W287470912 hasRelatedWork W2052501414 @default.
- W287470912 hasRelatedWork W2055251041 @default.
- W287470912 hasRelatedWork W2089290218 @default.
- W287470912 hasRelatedWork W2090697450 @default.
- W287470912 hasRelatedWork W2092470701 @default.
- W287470912 hasRelatedWork W2348260959 @default.
- W287470912 hasRelatedWork W2402385637 @default.
- W287470912 hasRelatedWork W2410745049 @default.
- W287470912 hasRelatedWork W2418831838 @default.
- W287470912 isParatext "false" @default.
- W287470912 isRetracted "false" @default.
- W287470912 magId "287470912" @default.
- W287470912 workType "article" @default.